Guy Montay

2.4k total citations
60 papers, 2.0k citations indexed

About

Guy Montay is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Guy Montay has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 23 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Guy Montay's work include Antibiotics Pharmacokinetics and Efficacy (30 papers), Drug Transport and Resistance Mechanisms (11 papers) and Cancer Treatment and Pharmacology (11 papers). Guy Montay is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (30 papers), Drug Transport and Resistance Mechanisms (11 papers) and Cancer Treatment and Pharmacology (11 papers). Guy Montay collaborates with scholars based in France, United States and Austria. Guy Montay's co-authors include René Bruno, J. Vergniol, Nicole Vivier, Françoise Roquet, A. Le Liboux, Armand Frydman, Lewis B. Sheiner, Vijay O. Bhargava, Michel G. Bergeron and Gerald Rhodes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Antimicrobial Agents and Chemotherapy and Anesthesiology.

In The Last Decade

Guy Montay

58 papers receiving 1.8k citations

Peers

Countries citing papers authored by Guy Montay

Since Specialization

Citations

This map shows the geographic impact of Guy Montay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Montay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Montay more than expected).

Fields of papers citing papers by Guy Montay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Montay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Montay. The network helps show where Guy Montay may publish in the future.

Co-authorship network of co-authors of Guy Montay

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Montay. A scholar is included among the top collaborators of Guy Montay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Montay. Guy Montay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Pharmacokinetics of Telithromycin, the First Ketolide Antibacterial 2005 ·Clinical Pharmacokinetics ·Jun Yi Shi, Guy Montay, Vijay O. Bhargava	48
2	Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal Impairment 2004 ·The Journal of Clinical Pharmacology ·Jun Yi Shi, Guy Montay, Sunny Chapel, Pierre Hardy, Jeffrey S. Barrett, Marshall Sack, Thomas Marbury, Suzanne K. Swan, Ramón Vargas, V. Leclerc, Bruno Leroy, Vijay O. Bhargava	32
3	Pharmacokinetics and Absolute Oral Bioavailability of an 800-mg Oral Dose of Telithromycin in Healthy Young and Elderly Volunteers 2002 ·Chemotherapy ·Claudio Perret, B. Lenfant, (unknown), D. H. Wessels, H. E. Scholtz, Guy Montay, (unknown)	43
4	Multiple‐Dose Pharmacokinetics and Safety of Two Regimens of Quinupristm/Dalfopristin (Synercid®) in Healthy Volunteers 2001 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Olivier Pasquier, Régine Rouzier‐Panis, (unknown), Guy Montay	5
5	Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for Docetaxel 2001 ·Investigational New Drugs ·René Bruno, Nicole Vivier, (unknown), Guy Montay, Gerald Rhodes	88
6	Pharmacokinetics of Ketoprofen Syrup in Small Children 2000 ·The Journal of Clinical Pharmacology ·Merja Kokki, A. Le Liboux, Antti Jekunen, Guy Montay, M. Heikkinen	13
7	Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown), (unknown), (unknown), Guy Montay, Laurent Vernillet, (unknown), (unknown)	46
8	Simultaneous high-performance liquid chromatographic determination of quinupristin, dalfopristin and their main metabolites in human plasma 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·A. Le Liboux, Olivier Pasquier, Guy Montay	13
9	The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans 1997 ·Journal of Antimicrobial Chemotherapy ·Michel G. Bergeron, Guy Montay	52
10	Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects 1997 ·The Journal of Clinical Pharmacology ·A. Le Liboux, (unknown), Y. Le Roux, Philippe Truffinet, (unknown), Stéphane Kirkesseli, Guy Montay	68
11	Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia 1995 ·Journal of Antimicrobial Chemotherapy ·(unknown), Guy Montay, (unknown), J. F. Desnottes	13
12	Aprikalim: Radioimmunoassay and Pharmacokinetic Studies in Mouse, Monkey, and Dog 1994 ·Journal of Pharmaceutical Sciences ·(unknown), (unknown), Guy Montay, Armand Frydman	5
13	Pharmacokinetic and pharmacodynamic study of suriclone imipramine interaction in man 1994 ·Fundamental and Clinical Pharmacology ·(unknown), (unknown), S. Bouquet, P. Chevalier, Guy Montay, J. Gaillot, (unknown), Philippe Guillet, B Vandel	1
14	A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500 1992 ·Journal of Antimicrobial Chemotherapy ·(unknown), Guy Montay, A. Le Liboux, Armand Frydman, (unknown)	50
15	Influence of rifampin on the pharmacokinetics of pefloxacin 1991 ·Clinical Pharmacology & Therapeutics ·Guy Humbert, (unknown), Guy Montay, A. Le Liboux, Armand Frydman, F. Borsa-Lebas, Nicholas Moore	11
16	Comparative Bioavailability Study of Cefixime Administered as Tablets or Aqueous Solution 1991 ·Drugs ·Guy Montay, (unknown), Y. Le Roux, A. Le Liboux, (unknown), D Chassard, J.J. Thebault, (unknown), Armand Frydman	11
17	A comparative pharmacokinetic and pharmacodynamic study of conventional and sustained‐release preparations of acebutolol in healthy volunteers 1991 ·Fundamental and Clinical Pharmacology ·O. Fleurot, Brigitte Lecocq, (unknown), A. Le Liboux, Guy Montay, Armand Frydman, Patrice Jaillon	1
18	Pharmacokinetics of fluoroquinolones in hepatic failure 1990 ·Journal of Antimicrobial Chemotherapy ·Guy Montay, J. Gaillot	22
19	[Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg]. 1989 ·PubMed ·Guy Montay, A. Le Liboux, J.J. Thebault, (unknown), Armand Frydman, J. Gaillot	6
20	[Diffusion of fluoroquinolones in the aqueous humor and crystalline lens]. 1987 ·PubMed ·C Lafaix, (unknown), (unknown), F Forestier, Guy Montay, A. Meulemans	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact